May 7, 2021 Message from SARC President & CEO “I’d like to share an abridged view into some of SARC’s present and future research initiatives and strategic planning to evolve SARC’s collaborative model for even greater impact…Among the areas … Read more
April 23, 2021 SARC Meeting at ASCO 2021 June 4 Save the date! The SARC semiannual (virtual) meeting at ASCO, will be held the morning of Friday, June 4th, 9:00 am–noon Eastern Time. Read more
April 3, 2021 Sarcoma at NIH 2021 Rare Disease Day Sarcoma was highlighted during 2021 Rare Disease Day at the National Institute for Health (NIH). Dr. Francis Collins, NIH Director noted “We’ve made real progress in these 10 years, first … Read more
March 19, 2021 Sarcoma Coalition March 2021 General Meeting The Sarcoma Coalition welcomed Nilsa Ramirez, MD, Director of the Biopathology Center at the Abigail Wexner Research Institute at Nationwide Children’s Hospital to discuss patient advocacy considerations related to biospecimen … Read more
March 9, 2021 A message from SARC Medical Officer Scott Okuno: Open Clinical Trials Message (excerpt) from Dr. Okuno to SARC Members: SARC has several “open, active, enrolling clinical trials [including] extremity soft tissue sarcoma trial using radiation therapy and immunotherapy neoadjuvantly…for advanced metastatic … Read more
January 15, 2021 New Study in Ewing Sarcoma Open to Enrollment SARC037 is a phase I study protocol to determine the recommended dose of trabectedin given as a 1-hour infusion in combination with low dose irinotecan. All patients enrolled will receive trabectedin combination … Read more
December 10, 2020 Life Raft Group’s Recognizing Women in Sarcoma Gala SARC celebrates Denise Reinke as she received the Women Paving the Path Forward Award at the Life Raft Group’s Recognizing Women in Sarcoma Gala. The Women in Sarcoma series highlights … Read more
December 1, 2020 Launch of Phase 2 Clinical Trial for Patients with Clear Cell Sarcoma of Soft Tissue SARC is proud to partner with Sara’s Cure and Rafael Pharmaceuticals for the Launch of Phase 2 Clinical Trial for CPI-613® (devimistat) in Combination with Hydroxychloroquine for Patients with Clear … Read more
November 30, 2020 Open Accruing SARC Studies Open accruing studies for you to refer or enroll your patients: SARC024 for Rhabdomyosarcoma (alveolar and embryonal) and Mesenchymal Chondrosarcoma SARC031 for Unresectable or Metastatic NF1 Associated or Sporadic Malignant Peripheral Nerve … Read more
November 6, 2020 SARC Meeting at CTOS 2020 The SARC Meeting at the 2020 CTOS Virtual Annual Meeting will be held Wednesday, November 18 from 1:00–3:00 pm Eastern. Read more